Ionic Aliance Group ISO 13485-2016 API Manufacturer
The Ionic Alliance Group, certified under ISO 13485:2016, manufactures Active Pharmaceutical Ingredients (APIs). ISO 13485:2016 is a globally recognized standard that specifies requirements for a quality management system. An organization must demonstrate its ability to provide medical devices and related services that consistently meet customer and applicable regulatory requirements. As an API manufacturer with this certification, Ionic Alliance Group adheres to stringent quality management principles, including designing, developing, producing, and distributing APIs. This ensures their products meet international regulatory standards and customer expectations for safety, reliability, and quality in the healthcare industry.
For more information, refer to the attached file.
Related Articles
Corporate Brochure for IAG
The Ionic Alliance Group “IAG” is leading the international research, development, and manufacturing of IBAL, a new form of biotechnology. The Ionic Alliance Community fosters a collaborative environment where information, ideas, and data relating to ...
Modification to the Conditions of the Sanitary Registration COFEPRIS for the Ion Gel ZCM-25®
At the beginning of 2023, a request was made to the Federal Commission for Prevention and Sanitary Risks (COFEPRIS) for a change of National Manufacturer. Finally, on March 22, 2024, Zeyco Laboratories S.A. de C.V. was approved as the manufacturer of ...
Ion Gel ZCM-25® Technical Data Sheet
Read detailed insights into the composition, physical properties, and safety profile of Ion Gel ZCM-25®. For more information, refer to the attached file.
Corporate Brochures for IBM
Ion Biotechnology México S.A. de C.V. is dedicated to bringing the benefits of Ion Biotechnology Aqueous Ligands (IBAL) to Latino markets. Our aim is to expand throughout Central and South American regions, ensuring widespread access to these ...
Ion Biotechnology Mexico Corporate Brochure
Ion Biotechnology México S.A de C.V. is focused on introducing Ion Biotechnology Aqueous Ligands (IBAL) to Latino markets in Central and South America, with the goal of ensuring widespread access to innovative therapies. Our strategic approach ...